Artificial Intelligence and Machine Learning Company Focused on Social Media Discovery and Fake News Detection
Clients Include: Canadian Federal Government, DRDC, Health Canada, United States Air Force and LOTTE
Mr. Gunter’s engineering background is rooted in big data analysis and machine learning at scale. Working with Sequoia Capital and Lightspeed Venture Partners, Marshall was responsible for bringing Varagesale to the mass market. Marshall took Varagesale from a one room shop to a powerhouse engineering department of 60 plus people and played a leading role in their $35-million-dollar raise. Marshall led the team that built iSentium’s sentiment engine. iSentium uses patented Natural Language Processing (NLP) to extract sentiment from unstructured social content then instantly transforms it into highly actionable indicators in finance, brand management and politics, handling billions of data points to harness the power of the masses as they tweet and text.
Andrew Ryu is a seasoned and experienced entrepreneur and operator in public and private companies. Graduate of McMaster University (1999) and University of Toronto (2000). Founder and CEO of TLA Inc. (1997-2005), President of business development of Archer Education Group (2005-2008), and founder and CEO of Loyalist Group Limited (TSXV: LOY) (2009-2014), which was nominated as the top TSXV company in 2013, ranked fourth in 2014, and was the top pick of the street in 2014. He served as CEO of Cozumo Inc. (2015-2016). He is currently serving as CEO and Chairman of Datametrex AI Limited (TSXV: DM) and Chairman of Graph Blockchain Inc. (CSE: GBLC). He was nominee of EY entrepreneur of the year in 2014.
Steve Kang is a seasoned finance and accounting professional. Steve has acquired a wealth of finance expertise and experience over 25 years from working at Honeywell, LG Electronics, and various accounting firms and public companies in Canada. He served as a VP in Finance at Loyalist Education Group Limited, which was nominated as the top TSXV company in 2013, ranked fourth in 2014, and was the top pick of the street in 2014. Most recently, as CFO and VP finance, he spearheaded Datametrex Ltd’s qualifying transaction with Everfront Ventures Corp. (currently Datametrex AI Limited) in June 2017 and Datametrex is now a listed company on the TSXV. He has attained a B.A. in Economics from Korea University and has obtained Certified Management Accountant (USA) and Chartered Professional Accountant, CGA (Ontario) designations.
Dr. Alexander MacGregor
A leader in the fields of pharmaceutical technology, research, and training, Dr. MacGregor has served as the President and Dean of Faculty of the Toronto Institute of Pharmaceutical Technology (TIPT®) since 1992.
The holder of several scientific patents, Dr. MacGregor currently oversees clinical testing trials of several drugs in the areas of cholesterol lowering, diabetes, anti-infective, post-operative pain, epilepsy, and congestive heart failure.
Dr. MacGregor obtained his Ph.D. in clinical pharmacology from the University of London Postgraduate Medical School after earning B.Sc. (Honors) in Medical Biochemistry from the Cardif University in Wales. In 1997, Dr. MacGregor completed a Master-Class Certification Program in Pharmaceutical Technology from the European Continuing Education College at the University of Liverpool.